Agency Information Collection Activities; Proposed Collection; Comment Request; Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products, 26281-26283 [2012-10645]

Download as PDF Federal Register / Vol. 77, No. 86 / Thursday, May 3, 2012 / Notices Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD 20850; Telephone (toll free): (866) 403–3697; Telephone (local): (301) 427–1111; TTY (toll free): (866) 438–7231; TTY (local): (301) 427–1130; Email: pso@AHRQ.hhs. gov. SUPPLEMENTARY INFORMATION: Background The Patient Safety Act, Public Law 109–41, 42 U.S.C. 299b–21—b–26, provides for the formation of PSOs, which collect, aggregate, and analyze confidential information regarding the quality and safety of health care delivery. The Patient Safety Rule, 42 CFR Part 3, authorizes AHRQ, on behalf of the Secretary of HHS, to list as a PSO an entity that attests that it meets the statutory and regulatory requirements for listing. A PSO can be ‘‘delisted’’ by the Secretary if it is found to no longer meet the requirements of the Patient Safety Act and Patient Safety Rule. Section 3.108(d) of the Patient Safety Rule requires AHRQ to provide public notice when it removes an organization from the list of federally approved PSOs, including when a PSO chooses to voluntarily relinquish its status as a PSO for any reason. Accordingly, CareRise LLC, PSO number P0058, was delisted effective at 12:00 Midnight ET (2400) on March 30, 2012. More information on PSOs can be obtained through AHRQ’s PSO Web site at https://www.pso.AHRQ.gov/index. html. Dated: April 24, 2012. Carolyn M. Clancy, Director. BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality National Advisory Council for Healthcare Research and Quality: Request for Nominations for Public Members Agency for Healthcare Research and Quality (AHRQ), HHS. ACTION: Notice of request for nominations for public members. wreier-aviles on DSK7SPTVN1PROD with NOTICES AGENCY: 42 U.S.C. 299c establishes a National Advisory Council for Healthcare Research and Quality (the Council). The Council is to advise the Secretary of HHS (Secretary) and the Director of the Agency for Healthcare Research and Quality (AHRQ) on SUMMARY: 15:32 May 02, 2012 Nominations should be sent to Ms. Karen Brooks, AHRQ, 540 Gaither Road, Room 3006, Rockville, Maryland 20850. Nominations may also be emailed to Karen.Brooks@ahrq.hhs.gov. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Jkt 226001 Ms. Karen Brooks, AHRQ, at (301) 427– 1801. 42 U.S.C. 299c provides that the Secretary shall appoint to the National Advisory Council for Healthcare Research and Quality twenty one appropriately qualified individuals. At least seventeen members shall be representatives of the public and at least one member shall be a specialist in the rural aspects of one or more of the professions or fields listed in the above summary. In addition, the Secretary designates, as ex officio members, representatives from other Federal agencies, principally agencies that conduct or support health care research, as well as Federal officials the Secretary may consider appropriate. 42 U.S.C. 299c(c)(3). The Council meets in the Washington, DC, metropolitan area, generally in Rockville, Maryland, approximately three times a year to provide broad guidance to the Secretary and AHRQ’s Director on the direction of and programs undertaken by AHRQ. Seven individuals will be selected presently by the Secretary to serve on the Council beginning with the meeting in the spring of 2012. Members SUPPLEMENTARY INFORMATION: [FR Doc. 2012–10596 Filed 5–2–12; 8:45 am] VerDate Mar<15>2010 matters related to activities of the Agency to improve the quality, safety, efficiency, and effectiveness of health care for all Americans. Seven current members’ terms will expire in November 2012. To fill these positions, we are seeking individuals who are distinguished: (1) In the conduct of research, demonstration projects, and evaluations with respect to health care; (2) in the fields of health care quality research or health care improvement; (3) in the practice of medicine; (4) in other health professions; (5) in representing the private health care sector (including health plans, providers, and purchasers) or administrators of health care delivery systems; (6) in the fields of health care economics, information systems, law, ethics, business, or public policy; and, (7) in representing the interests of patients and consumers of health care. 42 U.S.C. 299c(c)(2). Individuals are particularly sought with experience and success in activities specified in the summary above. DATES: Nominations should be received on or before 60 days after date of publication. PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 26281 generally serve 3-year terms. Appointments are staggered to permit an orderly rotation of membership. Interested persons may nominate one or more qualified persons for membership on the Council. Selfnominations are accepted. Nominations shall include: (1) A copy of the nominee’s resume or curriculum vitae; and (2) a statement that the nominee is willing to serve as a member of the Council. Selected candidates will be asked to provide detailed information concerning their financial interests, consultant positions and research grants and contracts, to permit evaluation of possible sources of conflict of interest. Please note that once you are nominated, AHRQ may consider your nomination for future positions on the Council. Federally registered lobbyists are not permitted to serve on this advisory board pursuant to the Presidential Memorandum entitled ‘‘Lobbyists on Agency Boards and Commissions’’ dated June 10, 2010, and the Office of Management and Budget’s ‘‘Final Guidance on Appointment of Lobbyists to Federal Boards and Commissions,’’ 76 FR 61756 (October 5, 2011). The Department seeks a broad geographic representation. In addition, AHRQ conducts and supports research concerning priority populations, which include: Low-income groups; minority groups; women; children; the elderly; and individuals with special health care needs, including individuals with disabilities and individuals who need chronic care or end-of-life health care. See 42 U.S.C. 299(c). Nominations of persons with expertise in health care for these priority populations are encouraged. Dated: April 24, 2012. Carolyn M. Clancy, Director. [FR Doc. 2012–10595 Filed 5–2–12; 8:45 am] BILLING CODE 4160–90–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No.FDA–2012–N–0386] Agency Information Collection Activities; Proposed Collection; Comment Request; Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products AGENCY: Food and Drug Administration, HHS. E:\FR\FM\03MYN1.SGM 03MYN1 26282 ACTION: Federal Register / Vol. 77, No. 86 / Thursday, May 3, 2012 / Notices Notice. The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the Agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal Agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the proposed extension of an existing collection of information pertaining to registration and product listing for owners and operators of domestic tobacco product establishments and to listing of ingredients in tobacco products under the Family Smoking Prevention and Tobacco Control Act (the Tobacco Control Act). DATES: Submit either electronic or written comments on the collection of information by July 2, 2012. ADDRESSES: Submit electronic comments on the collection of information to https:// www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 5156, daniel.gittleson@fda.hhs.gov. SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501–3520), Federal Agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. ‘‘Collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes Agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires Federal Agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, FDA is publishing notice wreier-aviles on DSK7SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 15:32 May 02, 2012 Jkt 226001 of the proposed collection of information set forth in this document. With respect to the following collection of information, FDA invites comments on these topics: (1) Whether the proposed collection of information is necessary for the proper performance of FDA’s functions, including whether the information will have practical utility; (2) the accuracy of FDA’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques, when appropriate, and other forms of information technology. Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments and Listing of Ingredients in Tobacco Products (OMB Control Number 0910– 0650)—Extension On June 22, 2009, the President signed the Tobacco Control Act (Pub. L. 111–31) into law. The Tobacco Control Act amended the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 301 et seq.) by, among other things, adding a new chapter granting the FDA important new authority to regulate the manufacture, marketing, and distribution of tobacco products to protect the public health generally and to reduce tobacco use by minors. Section 905(b) of the FD&C Act (21 U.S.C. 395(b)), as amended by the Tobacco Control Act, requires that ‘‘every person who owns or operates any establishment in any State engaged in the manufacture, preparation, compounding, or processing of a tobacco product or tobacco products * * *’’ register with the FDA the name, places of business, and all establishments owned operated by that person. Every person must register by December 31 of each year. Section 905(c) of the FD&C Act requires that first-time persons ‘‘engaging in the manufacture, preparation, compounding, or processing of a tobacco product or tobacco products shall register with the Secretary the name, places of business, and all such establishments of that person.’’ Section 905(d) states that persons required to register under sections 905(b) or 905(c) shall register any additional establishment that they own or operate in any state which begins the manufacture, preparation, compounding, or processing of a PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 tobacco product or tobacco products. Section 905(h) addresses foreign establishment registration requirements, which will go into effect when regulations are promulgated by the Secretary. Section 905(i)(1) of the FD&C Act, as amended by the Tobacco Control Act, requires that all registrants ‘‘shall, at the time of registration under any such subsection, file with [FDA] a list of all tobacco products which are being manufactured, prepared, compounded, or processed by that person for commercial distribution,’’ along with certain accompanying consumer information, such as all labeling and a representative sampling of advertisements. Section 904(a)(1) of the FD&C Act, as amended by the Tobacco Control Act, requires each tobacco product manufacturer or importer, or agent thereof, to submit ‘‘a listing of all ingredients, including tobacco, substances, compounds, and additives that are * * * added by the manufacturer to the tobacco, paper, filter, or other part of each tobacco product by brand or by quantity in each brand and subbrand.’’ Since the Tobacco Control Act was enacted on June 22, 2009, the information required under section 904(a)(1) must be submitted to FDA by December 22, 2009, and include the ingredients added as of the date of submission. Section 904(c) of the FD&C Act also requires submission of information whenever additives, or the quantities of additives, are changed. FDA issued guidance documents on both: (1) Registration and Product Listing for Owners and Operators of Domestic Tobacco Product Establishments (November 12, 2009, 74 FR 58298) and (2) Listing of Ingredients in Tobacco Products (December 1, 2009, 74 FR 62795) to assist persons making such submissions to FDA under the Tobacco Control Act. While electronic submission of registration and product listing information and ingredient listing information are not required, FDA is strongly encouraging electronic submission to facilitate efficiency and timeliness of data management and collection. To that end, FDA designed the eSubmitter application to streamline the data entry process for registration and product listing and for ingredient listing. This tool allows for importation of large quantities of structured data, attachment of files (e.g., in portable document format (PDFs) and certain media files), and automatic acknowledgement of FDA’s receipt of submissions. FDA also developed paper forms (Form FDA 3742—Registration and Listing for Owners and Operators of E:\FR\FM\03MYN1.SGM 03MYN1 26283 Federal Register / Vol. 77, No. 86 / Thursday, May 3, 2012 / Notices Domestic Tobacco Product Establishments and Form FDA 3743— Listing of Ingredients in Tobacco Products) as an alternative submission tool. Both the eSubmitter application and the paper forms can be accessed at https://www.fda.gov/tobacco. FDA form/ activity/TCA section Number of respondents Number of responses per respondent FDA estimates the burden of this collection of information as follows: Total annual responses Hours per response Total hours Form FDA 3742 Registration and Product Listing for Owners and Operators of Domestic Establishments (Electronic and Paper submission) Sections 905(b), 905(c), 905(d) 905(h), or 905(i) .................................................... Form FDA 3743 Listing of Ingredients (Electronic and Paper Submissions) Sections 904(a)(1) or 904(c) .......... Obtaining a DUNS Number (10% of total respondents) ..... 125 1.6 200 3.75 750 125 8 1.6 1 200 8 3.00 0.50 600 4 Total .............................................................................. ........................ ........................ ........................ ........................ 1,354 wreier-aviles on DSK7SPTVN1PROD with NOTICES 1 There are no capital costs or operating and maintenance costs associated with this collection of information. Since this collection of information was last approved by OMB on December 2, 2010, its burden has decreased by 407,421 hours, from 408,775 to 1,354 reporting hours. This adjustment is a result of FDA experience over the past 2 years in the regulation of tobacco products and is based on the actual number of establishment registration and product ingredient submissions received during this time period. In 2010, when this collection was first published for public comment in the Federal Register, FDA attempted to determine the actual number of tobacco manufacturers by using the Security and Exchange Commission’s Standard Industrial Classification (SIC) codes, which are identifying codes that appear in a company’s EDGAR filings to show the company’s type of business. When preparing the collection of information package for publication in 2010, the tobacco industry codes indicated that over 10,000 tobacco manufacturers existed under the SIC codes for tobacco products and cigarettes. However, upon further examination of these codes, it appears that the number of tobacco manufacturers was greatly inflated, as the SIC codes included tobacco retail in addition to tobacco manufacturers. In addition, no comments were received from the 2010 initial 60-Day Federal Register Notice regarding either the number of respondents or the number of reporting burden hours listed in the notice, so FDA used the collection’s SIC-researched manufacturer numbers for this collection of information. Actual FDA registration and product listing report submissions and FDA experience indicate in the past 2 years, the number of tobacco manufacturers required to register and list their products and ingredient listings is approximately 125, a substantial decrease from the number of potential respondents listed in 2010. By applying the revised number of VerDate Mar<15>2010 15:32 May 02, 2012 Jkt 226001 manufacturers to the burden chart, the total burden for registration and listing now is currently estimated to be 1,354 reporting burden hours, much less than the 408,775 OMB-approved reporting burden hours stated in 2010. Based on the actual number of registration and product ingredient listing reports received by FDA over the past 2 years, the number of expected annual responses is projected to decrease from 100,000 registration responses to 200 annual responses, and from 11,000 annual product ingredient listing responses to 200 annual product ingredient responses. The Agency bases its estimate on the actual number of registration and listing and product ingredient listing reports received, its experience with the submission of registration and listing requirements applicable to other FDA regulated products, and ongoing interactions with industry. FDA estimates that the submission of registration information as required by section 905 of the FD&C Act will remain at 3.75 hours per establishment. Based on the actual number of registration information submitted over the past 2 years and its experience, the Agency estimates that approximately 200 registrations will be submitted from 125 tobacco product establishments annually, for a total 750 hour burden (125 respondents × 1.6 responses per respondent × 3.75 hours per response). FDA estimates that the submission of ingredient listing information as required by section 904 of the FD&C Act will remain at 3.0 hours per tobacco product. Based on the actual number of product ingredient listings submitted over the past 2 years and its experience, the Agency estimates that approximately 200 ingredient listings will be submitted from 125 tobacco establishments, for a total 600 burden hours (125 respondents × 1.6 responses PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 per respondent × 3.0 hours per response). FDA estimates that obtaining a Dun and Bradstreet (DUNS) number will take 0.5 hours, and that 8 respondents (1 percent (1.25) of establishments required to register under section 905 and 5 percent (6.25) of submitters required to list ingredients under section 904) will not already have a DUNS number. The total burden, therefore, will be 4 hours (8 respondents × 1 response per respondent × 0.5 hours per response). Total burden hours for this collection, therefore is 1,354 hours (750 + 600 + 4 hours). Dated: April 26, 2012. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2012–10645 Filed 5–2–12; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2011–N–0781] Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995. SUMMARY: E:\FR\FM\03MYN1.SGM 03MYN1

Agencies

[Federal Register Volume 77, Number 86 (Thursday, May 3, 2012)]
[Notices]
[Pages 26281-26283]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-10645]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No.FDA-2012-N-0386]


Agency Information Collection Activities; Proposed Collection; 
Comment Request; Registration and Product Listing for Owners and 
Operators of Domestic Tobacco Product Establishments and Listing of 
Ingredients in Tobacco Products

AGENCY: Food and Drug Administration, HHS.

[[Page 26282]]


ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an 
opportunity for public comment on the proposed collection of certain 
information by the Agency. Under the Paperwork Reduction Act of 1995 
(the PRA), Federal Agencies are required to publish notice in the 
Federal Register concerning each proposed collection of information, 
including each proposed extension of an existing collection of 
information, and to allow 60 days for public comment in response to the 
notice. This notice solicits comments on the proposed extension of an 
existing collection of information pertaining to registration and 
product listing for owners and operators of domestic tobacco product 
establishments and to listing of ingredients in tobacco products under 
the Family Smoking Prevention and Tobacco Control Act (the Tobacco 
Control Act).

DATES: Submit either electronic or written comments on the collection 
of information by July 2, 2012.

ADDRESSES: Submit electronic comments on the collection of information 
to https://www.regulations.gov. Submit written comments on the 
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852. All comments should be identified with the docket 
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-5156, 
daniel.gittleson@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal 
Agencies must obtain approval from the Office of Management and Budget 
(OMB) for each collection of information they conduct or sponsor. 
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes Agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) 
requires Federal Agencies to provide a 60-day notice in the Federal 
Register concerning each proposed collection of information, including 
each proposed extension of an existing collection of information, 
before submitting the collection to OMB for approval. To comply with 
this requirement, FDA is publishing notice of the proposed collection 
of information set forth in this document.
    With respect to the following collection of information, FDA 
invites comments on these topics: (1) Whether the proposed collection 
of information is necessary for the proper performance of FDA's 
functions, including whether the information will have practical 
utility; (2) the accuracy of FDA's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used; (3) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (4) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques, when 
appropriate, and other forms of information technology.

Registration and Product Listing for Owners and Operators of Domestic 
Tobacco Product Establishments and Listing of Ingredients in Tobacco 
Products (OMB Control Number 0910-0650)--Extension

    On June 22, 2009, the President signed the Tobacco Control Act 
(Pub. L. 111-31) into law. The Tobacco Control Act amended the Federal 
Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 301 et seq.) by, 
among other things, adding a new chapter granting the FDA important new 
authority to regulate the manufacture, marketing, and distribution of 
tobacco products to protect the public health generally and to reduce 
tobacco use by minors.
    Section 905(b) of the FD&C Act (21 U.S.C. 395(b)), as amended by 
the Tobacco Control Act, requires that ``every person who owns or 
operates any establishment in any State engaged in the manufacture, 
preparation, compounding, or processing of a tobacco product or tobacco 
products * * *'' register with the FDA the name, places of business, 
and all establishments owned operated by that person. Every person must 
register by December 31 of each year. Section 905(c) of the FD&C Act 
requires that first-time persons ``engaging in the manufacture, 
preparation, compounding, or processing of a tobacco product or tobacco 
products shall register with the Secretary the name, places of 
business, and all such establishments of that person.'' Section 905(d) 
states that persons required to register under sections 905(b) or 
905(c) shall register any additional establishment that they own or 
operate in any state which begins the manufacture, preparation, 
compounding, or processing of a tobacco product or tobacco products. 
Section 905(h) addresses foreign establishment registration 
requirements, which will go into effect when regulations are 
promulgated by the Secretary. Section 905(i)(1) of the FD&C Act, as 
amended by the Tobacco Control Act, requires that all registrants 
``shall, at the time of registration under any such subsection, file 
with [FDA] a list of all tobacco products which are being manufactured, 
prepared, compounded, or processed by that person for commercial 
distribution,'' along with certain accompanying consumer information, 
such as all labeling and a representative sampling of advertisements. 
Section 904(a)(1) of the FD&C Act, as amended by the Tobacco Control 
Act, requires each tobacco product manufacturer or importer, or agent 
thereof, to submit ``a listing of all ingredients, including tobacco, 
substances, compounds, and additives that are * * * added by the 
manufacturer to the tobacco, paper, filter, or other part of each 
tobacco product by brand or by quantity in each brand and subbrand.'' 
Since the Tobacco Control Act was enacted on June 22, 2009, the 
information required under section 904(a)(1) must be submitted to FDA 
by December 22, 2009, and include the ingredients added as of the date 
of submission. Section 904(c) of the FD&C Act also requires submission 
of information whenever additives, or the quantities of additives, are 
changed.
    FDA issued guidance documents on both: (1) Registration and Product 
Listing for Owners and Operators of Domestic Tobacco Product 
Establishments (November 12, 2009, 74 FR 58298) and (2) Listing of 
Ingredients in Tobacco Products (December 1, 2009, 74 FR 62795) to 
assist persons making such submissions to FDA under the Tobacco Control 
Act. While electronic submission of registration and product listing 
information and ingredient listing information are not required, FDA is 
strongly encouraging electronic submission to facilitate efficiency and 
timeliness of data management and collection. To that end, FDA designed 
the eSubmitter application to streamline the data entry process for 
registration and product listing and for ingredient listing. This tool 
allows for importation of large quantities of structured data, 
attachment of files (e.g., in portable document format (PDFs) and 
certain media files), and automatic acknowledgement of FDA's receipt of 
submissions. FDA also developed paper forms (Form FDA 3742--
Registration and Listing for Owners and Operators of

[[Page 26283]]

Domestic Tobacco Product Establishments and Form FDA 3743--Listing of 
Ingredients in Tobacco Products) as an alternative submission tool. 
Both the eSubmitter application and the paper forms can be accessed at 
https://www.fda.gov/tobacco.
    FDA estimates the burden of this collection of information as 
follows:

----------------------------------------------------------------------------------------------------------------
                                                     Number of
  FDA form/ activity/TCA section      Number of    responses per   Total annual      Hours per      Total hours
                                     respondents     respondent      responses       response
----------------------------------------------------------------------------------------------------------------
Form FDA 3742 Registration and                125            1.6             200            3.75             750
 Product Listing for Owners and
 Operators of Domestic
 Establishments (Electronic and
 Paper submission) Sections
 905(b), 905(c), 905(d) 905(h),
 or 905(i).......................
Form FDA 3743 Listing of                      125            1.6             200            3.00             600
 Ingredients (Electronic and
 Paper Submissions) Sections
 904(a)(1) or 904(c).............
Obtaining a DUNS Number (10% of                 8            1                 8            0.50               4
 total respondents)..............
                                  ------------------------------------------------------------------------------
    Total........................  ..............  .............  ..............  ..............           1,354
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    Since this collection of information was last approved by OMB on 
December 2, 2010, its burden has decreased by 407,421 hours, from 
408,775 to 1,354 reporting hours. This adjustment is a result of FDA 
experience over the past 2 years in the regulation of tobacco products 
and is based on the actual number of establishment registration and 
product ingredient submissions received during this time period. In 
2010, when this collection was first published for public comment in 
the Federal Register, FDA attempted to determine the actual number of 
tobacco manufacturers by using the Security and Exchange Commission's 
Standard Industrial Classification (SIC) codes, which are identifying 
codes that appear in a company's EDGAR filings to show the company's 
type of business. When preparing the collection of information package 
for publication in 2010, the tobacco industry codes indicated that over 
10,000 tobacco manufacturers existed under the SIC codes for tobacco 
products and cigarettes. However, upon further examination of these 
codes, it appears that the number of tobacco manufacturers was greatly 
inflated, as the SIC codes included tobacco retail in addition to 
tobacco manufacturers. In addition, no comments were received from the 
2010 initial 60-Day Federal Register Notice regarding either the number 
of respondents or the number of reporting burden hours listed in the 
notice, so FDA used the collection's SIC-researched manufacturer 
numbers for this collection of information. Actual FDA registration and 
product listing report submissions and FDA experience indicate in the 
past 2 years, the number of tobacco manufacturers required to register 
and list their products and ingredient listings is approximately 125, a 
substantial decrease from the number of potential respondents listed in 
2010. By applying the revised number of manufacturers to the burden 
chart, the total burden for registration and listing now is currently 
estimated to be 1,354 reporting burden hours, much less than the 
408,775 OMB-approved reporting burden hours stated in 2010.
    Based on the actual number of registration and product ingredient 
listing reports received by FDA over the past 2 years, the number of 
expected annual responses is projected to decrease from 100,000 
registration responses to 200 annual responses, and from 11,000 annual 
product ingredient listing responses to 200 annual product ingredient 
responses. The Agency bases its estimate on the actual number of 
registration and listing and product ingredient listing reports 
received, its experience with the submission of registration and 
listing requirements applicable to other FDA regulated products, and 
ongoing interactions with industry. FDA estimates that the submission 
of registration information as required by section 905 of the FD&C Act 
will remain at 3.75 hours per establishment. Based on the actual number 
of registration information submitted over the past 2 years and its 
experience, the Agency estimates that approximately 200 registrations 
will be submitted from 125 tobacco product establishments annually, for 
a total 750 hour burden (125 respondents x 1.6 responses per respondent 
x 3.75 hours per response).
    FDA estimates that the submission of ingredient listing information 
as required by section 904 of the FD&C Act will remain at 3.0 hours per 
tobacco product. Based on the actual number of product ingredient 
listings submitted over the past 2 years and its experience, the Agency 
estimates that approximately 200 ingredient listings will be submitted 
from 125 tobacco establishments, for a total 600 burden hours (125 
respondents x 1.6 responses per respondent x 3.0 hours per response).
    FDA estimates that obtaining a Dun and Bradstreet (DUNS) number 
will take 0.5 hours, and that 8 respondents (1 percent (1.25) of 
establishments required to register under section 905 and 5 percent 
(6.25) of submitters required to list ingredients under section 904) 
will not already have a DUNS number. The total burden, therefore, will 
be 4 hours (8 respondents x 1 response per respondent x 0.5 hours per 
response).
    Total burden hours for this collection, therefore is 1,354 hours 
(750 + 600 + 4 hours).

    Dated: April 26, 2012.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2012-10645 Filed 5-2-12; 8:45 am]
BILLING CODE 4160-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.